Shanghai Rui Zhi Medicine Technology

ChemPartner is a leading global contract research organization (CRO) and contract development and manufacturing organization (CDMO) providing a comprehensive portfolio of services for drug discovery and development. Founded in 2003 and headquartered in Shanghai, the company supports biopharmaceutical clients across the entire R&D spectrum, from lead optimization and chemistry to biologics discovery and manufacturing. Their expertise spans multiple therapeutic areas, including oncology, immunology, and neuroscience, utilizing advanced platforms for small molecules and biologics. ChemPartner operates several state-of-the-art facilities in China, the US, and Europe, facilitating global drug innovation through high-quality research and technical excellence. The company offers integrated services including medicinal chemistry, biology, pharmacology, DMPK, and exploratory toxicology. With a strong track record of collaboration with major pharmaceutical companies and emerging biotechs, ChemPartner remains a key player in the global life sciences outsourcing market.